Alessandra Daigneault Biography and Net Worth

General Counsel of NRx Pharmaceuticals

Mrs. Daigneault joined NRx as its Corporate Secretary in September 2020. Prior to joining NRx, she was co-founder and Chief Operating Officer of Quantum Governance LLC, where she continues to serve as a director. She also served as Vice President and Chief Legal Counsel for Teligent, Inc. and its successor companies, First Avenue Networks and FiberTower Corporation, all publicly traded telecommunications companies, from October 2000 to May 2008. Ms. Daigneault began her legal career with Milbank LLP and was a Partner at the Washington, D.C. law firm of Tucker, Flyer & Lewis (now Venable LLP) where she represented clients on various corporate and commercial transactions. Ms. Daigneault holds a Bachelor of Science, Magna Cum Laude, from Georgetown University and a Juris Doctor from Georgetown University Law Center.

How do I contact Alessandra Daigneault?: The corporate mailing address for Ms. Daigneault and other NRx Pharmaceuticals executives is 2645 N. Federal Highway Suite 230, Delray Beach FL, 33483. NRx Pharmaceuticals can also be reached via phone at (484) 254-6134 and via email at [email protected]. Learn More on Alessandra Daigneault's contact information.
Has Alessandra Daigneault been buying or selling shares of NRx Pharmaceuticals?: Alessandra Daigneault has not been actively trading shares of NRx Pharmaceuticals during the past quarter. Most recently, Alessandra Daigneault sold 337 shares of the business's stock in a transaction on Monday, August 23rd. The shares were sold at an average price of $1,311.00, for a transaction totalling $441,807.00. Learn More on Alessandra Daigneault's trading history.
Who are NRx Pharmaceuticals' active insiders?: NRx Pharmaceuticals' insider roster includes Robert Besthof (Insider), and Alessandra Daigneault (General Counsel). Learn More on NRx Pharmaceuticals' active insiders.
Are insiders buying or selling shares of NRx Pharmaceuticals?: In the last year, NRx Pharmaceuticals insiders bought shares 1 times. They purchased a total of 40,000 shares worth more than $46,800.00. The most recent insider tranaction occured on December, 17th when Chairman Jonathan C Javitt bought 40,000 shares worth more than $46,800.00. Insiders at NRx Pharmaceuticals own 19.0% of the company. Learn More about insider trades at NRx Pharmaceuticals.
Information on this page was last updated on 12/17/2024.

Alessandra Daigneault Insider Trading History at NRx Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/23/2021	Sell	337	$1,311.00	$441,807.00

Alessandra Daigneault Buying and Selling Activity at NRx Pharmaceuticals

NRx Pharmaceuticals Company Overview

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned food and drug administration-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior. The company has a partnership with Alvogen Inc. and Lotus Pharmaceutical Company; development and manufacturing agreement with Nephron Pharmaceuticals, Inc. and Alcami; license agreement with Apkarian Technologies; development and license agreement with Glytech; license agreement with Sarah Herzog Memorial Hospital. The company was founded in 2015 and is based in Wilmington, Delaware.

Today's Range

Now: $2.44

$2.36

$2.51

50 Day Range

MA: $2.83

$2.03

$3.67

2 Week Range

Now: $2.44

$1.15

$6.01

Volume

356,150 shs

Average Volume

436,705 shs

Market Capitalization

$68.56 million

P/E Ratio

N/A

Dividend Yield